The biology of metastasis to a sanctuary site

被引：114
作者：
Palmieri, Diane
Chambers, Ann F.
Felding-Habermann, Brunhilde
Huang, Suyun
Steeg, Patricia S.
机构：
[1] NCI, Mol Therapeut Program, Ctr Canc Res, Lab Mol Pharmacol,Womens Canc Sect, Bethesda, MD 20892 USA
[2] Univ Western Ontario, Dept Oncol, London, ON, Canada
[3] Univ Western Ontario, Dept Pathol, London, ON, Canada
[4] Univ Western Ontario, Dept Med Biophys, London, ON, Canada
[5] London Reg Canc Program, London, ON, Canada
[6] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA
[7] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
来源：
CLINICAL CANCER RESEARCH | 2007年 / 13卷 / 06期
关键词：
D O I：
10.1158/1078-0432.CCR-06-2659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Metastasis to the brain is prevalent in solid tumors and lymphomas, and is associated with shortened survival. The brain is regarded as a sanctuary site for metastatic tumor cells where they exist partially protected from drugs by the blood-tumor barrier. Model systems for brain metastasis have been developed and are now yielding mechanistic insights into the roles of angiogenesis, energy metabolism, the Her-2 and Stat3 signaling pathways, and dormancy. Specific, new approaches to combat brain metastatic disease are needed.
引用
收藏
页码：1656 / 1662
页数：7
相关论文
共 74 条
  • [1] Targeting of melanoma brain metastases using engineered neural stem/progenitor cells
    Aboody, KS
    Najbauer, J
    Schmidt, NO
    Yang, W
    Wu, JK
    Zhuge, Y
    Przylecki, W
    Carroll, R
    Black, PM
    Perides, G
    [J]. NEURO-ONCOLOGY, 2006, 8 (02) : 119 - 126
  • [2] Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model - an MRI study
    Abramovitch, R
    Itzik, A
    Harel, H
    Nagler, A
    Vlodavsky, I
    Siegal, T
    [J]. NEOPLASIA, 2004, 6 (05): : 480 - 489
  • [3] [Anonymous], 1978, ADV NEUROL
  • [4] Pathology-based substrate for target definition in radiosurgery of brain metastases
    Baumert, Brigitta G.
    Rutten, Isabelle
    Dehing-Oberije, Cary
    Twijnstra, Albert
    Dirx, Miranda J. M.
    Debougnoux-Huppertz, Ria M. T. L.
    Lambin, Philippe
    Kubat, Bela
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 187 - 194
  • [5] Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
    Bendell, JC
    Domchek, SM
    Burstein, HJ
    Harris, L
    Younger, J
    Kuter, I
    Bunnell, C
    Rue, M
    Gelman, R
    Winer, E
    [J]. CANCER, 2003, 97 (12) : 2972 - 2977
  • [6] VEGF inhibitors in cancer therapy
    Cardones, AR
    Bañez, LL
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 387 - 394
  • [7] Dissemination and growth of cancer cells in metastatic sites
    Chambers, AF
    Groom, AC
    MacDonald, IC
    [J]. NATURE REVIEWS CANCER, 2002, 2 (08) : 563 - 572
  • [8] CHEN E, IN PRESS CANC RES
  • [9] Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer
    Clayton, AJ
    Danson, S
    Jolly, S
    Ryder, WDJ
    Burt, PA
    Stewart, AL
    Wilkinson, PM
    Welch, RS
    Magee, B
    Wilson, G
    Howell, A
    Wardley, AM
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 639 - 643
  • [10] Rodent models of brain metastasis in melanoma
    Cranmer, LD
    Trevor, KT
    Bandlamuri, S
    Hersh, EM
    [J]. MELANOMA RESEARCH, 2005, 15 (05) : 325 - 356
12345678